Why the study?
Optimal medication adherence is crucial for achieving treatment goals and preventing adverse outcomes in chronic conditions, prompting an exploration of the impact of gender on adherence in metabolic and cardiovascular diseases.
How does gender impact medication adherence in patients with metabolic and cardiovascular diseases?
Design
Review
Key result
Gender significantly impacts medication adherence in metabolic and cardiovascular diseases, with women generally exhibiting poorer adherence to therapies such as statins compared to men.
Authors
Loading...
May warrant gender-aware adherence monitoring in metabolic care; leaves open efficacy of tailored interventions.
How does gender impact medication adherence in patients with metabolic and cardiovascular diseases?
Gender differences in medication adherence are multifactorial, highlighting the need for gender-customized interventions to improve adherence and reduce the burden of metabolic and cardiovascular diseases.
Venditti et al. (2023) conducted a review in Metabolic and cardiovascular diseases. Medication adherence vs. Gender differences was evaluated on Medication adherence. Gender significantly impacts medication adherence in metabolic and cardiovascular diseases, with women generally exhibiting poorer adherence to therapies such as statins compared to men.